Product NDC: | 16103-367 |
Proprietary Name: | Bisacodyl |
Non Proprietary Name: | Bisacodyl |
Active Ingredient(s): | 5 mg/1 & nbsp; Bisacodyl |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, DELAYED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 16103-367 |
Labeler Name: | Pharbest Pharmaceuticals Inc. |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part334 |
Marketing Category: | OTC MONOGRAPH NOT FINAL |
Start Marketing Date: | 20060125 |
Package NDC: | 16103-367-17 |
Package Description: | 25 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (16103-367-17) |
NDC Code | 16103-367-17 |
Proprietary Name | Bisacodyl |
Package Description | 25 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (16103-367-17) |
Product NDC | 16103-367 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Bisacodyl |
Dosage Form Name | TABLET, DELAYED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20060125 |
Marketing Category Name | OTC MONOGRAPH NOT FINAL |
Labeler Name | Pharbest Pharmaceuticals Inc. |
Substance Name | BISACODYL |
Strength Number | 5 |
Strength Unit | mg/1 |
Pharmaceutical Classes |